Conditions: Atopic Dermatitis
Keywords: Atopic Dermatitis eczema
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 370
Healthy volunteers: no

Brief summary:
The purpose of this research study is to gather scientific information about the effectiveness of the study drug, ASB17061 capsules, when compared to placebo in adult subjects with atopic dermatitis.

Detailed description:

Arms:
arm 1: Oral administration of low dose ASB17061 taken once daily for 28 consecutive days. arm 2: Oral administration of middle dose ASB17061 taken once daily for 28 consecutive days. arm 3: Oral administration of high dose ASB17061 taken once daily for 28 consecutive days. arm 4: Oral administration of placebo taken once daily for 28 consecutive days.

Interventions: intervention 1: 5 mg ASB17061 intervention 2: Placebo intervention 3: 10 mg ASB17061 intervention 4: 20 mg ASB17061
Intervention descriptions: intervention 1: Oral administration of 5 mg ASB17061 taken once daily for 28 consecutive days. intervention 2: Oral administration of placebo taken once daily for 28 consecutive days. intervention 3: Oral administration of 10 mg ASB17061 taken once daily for 28 consecutive days. intervention 4: Oral administration of 20 mg ASB17061 taken once daily for 28 consecutive days.

Protocol document: